poisar

Stocks · News reference

GE Healthcare in Talks To Acquire Sofie Biosciences, Maker of Cancer Scan Chemicals

Crispus Nyaga

GE Healthcare Technologies is considering making its second-biggest acquisition as its stock continues its downward spiral.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

GEGEHCGEV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Can RTX's GTF Aftermarket Expansion Boost Its Growth Outlook?

    RTX Corporation is expanding its commercial aerospace aftermarket opportunity through Pratt & Whitney's growing Geared Turbofan (GTF) engine support network, which now spans 21 facilities worldwide. The GTF family powers over 2,600 aircraft across multiple platforms, creating recurring maintenance and repair opportunities. In 2025, the GTF Advantage engine received certification for the Airbus A320neo family, designed to offer higher thrust and improved fuel efficiency. Pratt & Whitney's sales grew to $32.9 billion in 2025, with operating profit reaching $2.6 billion.

    RTXGESAFRY
  4. Sns Insider

    Enterprise Imaging Solutions Market Set to Hit USD 6.69 Billion by 2035, Growing at a CAGR of 11.18% - SNS Insider

    The Enterprise Imaging Solutions Market is projected to grow from USD 2.32 billion in 2025 to USD 6.69 billion by 2035, with a CAGR of 11.18%. Growth is driven by cloud-native platforms, AI-driven workflows, and vendor consolidation. North America leads with 44% market share, while Asia-Pacific shows the fastest growth at 15% CAGR. Software remains the largest component at 58% share, with cloud deployment and services as the fastest-growing segments.

    GEHCUNHSCTAYSMMNYPHG
  5. Na

    GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance

    GE HealthCare Technologies has submitted its next-generation StarGuide GX digital SPECT/CT system for FDA 510(k) clearance following CE Mark approval in Europe. The system features dual-sided CZT detectors, NVIDIA RTX computing, and rapid collimator exchange, designed to support emerging radioligand therapies including alpha emitters like Actinium-225 and Lead-212. Despite the regulatory milestone, GEHC stock declined 3% following the announcement.

    GEHCVCYTGMEDWST